Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells

Bibliography

• White DE, Muller WJ. Multifaceted roles of integrins in breast cancer metastasis. J Mammary Gland Biol Neoplasia 2007;12(2-3):135-42
   PubMedGoogle Scholar
• Bohle AS, Kalthoff H. Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 1999;384(2):133-40
   PubMedGoogle Scholar
• Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002;2(10):795-803
   PubMed Web of Science ®Google Scholar
• Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25(4):581-611
   PubMed Web of Science ®Google Scholar
• Applanat MP, Buteau-Lozano H, Herve MA, Corpet A. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression. Adv Exp Med Biol 2008;617:437-44
   PubMedGoogle Scholar
• Price DJ, Miralem T, Jiang S, Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 2001;12(3):129-35
   PubMedGoogle Scholar
• Harris AL. Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2(1):38-47
   PubMed Web of Science ®Google Scholar
• Generali D, Berruti A, Brizzi MP, Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 2006;12(15):4562-8
   PubMed Web of Science ®Google Scholar
• Hiraga T, Kizaka-Kondoh S, Hirota K, Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Res 2007;67(9):4157-63
   PubMedGoogle Scholar
• Krishnamachary B, Penet MF, Nimmagadda S, Hypoxia regulates CD44 and its variant isoforms through HIF-1alpha in triple negative breast cancer. PLoS One 2012;7(8):e44078
   Google Scholar
• Yoon SO, Park SJ, Yun CH, Chung AS. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 2003;36(1):128-37
   PubMedGoogle Scholar
• Gout S, Huot J. Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 2008;1(1):69-83
   PubMedGoogle Scholar
• Liabakk NB, Talbot I, Smith RA, Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996;56(1):190-6
   PubMedGoogle Scholar
• Peng L, Huang R, Zhang S, Hertz L. Ouabain binding kinetics and FXYD7 expression in astrocytes and neurons in primary cultures: implications for cellular contributions to extracellular K+ homeostasis? Neuron Glia Biol 20106(2):127-35
   PubMedGoogle Scholar
• Gonzalez LO, Pidal I, Junquera S, Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse. Br J Cancer 2007;97(7):957-63
   PubMedGoogle Scholar
• Yamamoto S, Aizu E, Jiang H, The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis 1991;12(2):317-23
   PubMed Web of Science ®Google Scholar
• Chan SC, Chang YS, Wang JP, Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med 1998;64(2):153-8
   PubMed Web of Science ®Google Scholar
• Chin YW, Jung HA, Liu Y, Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra). J Agric Food Chem 2007;55(12):4691-7
   PubMed Web of Science ®Google Scholar
• Kwon GT, Cho HJ, Chung WY, Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 2009;20(9):663-76
   PubMedGoogle Scholar
• Kang SW, Choi JS, Choi YJ, Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases. J Nutr Biochem 2010;21(1):55-65
   PubMedGoogle Scholar
• Takahashi T, Takasuka N, Iigo M, Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 2004;95(5):448-53
   PubMed Web of Science ®Google Scholar
• Chen MC, Yu CH, Wang SW, Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO. J Cell Biochem 2010;110(6):1495-503
   PubMedGoogle Scholar
• Wu JJ, Wang KL, Wang SW, Differential effects of nonylphenol on testosterone secretion in rat Leydig cells. Toxicology 2010;268(1-2):1-7
   PubMedGoogle Scholar
• Jones JI, Gockerman A, Busby WH Jr, Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993;90(22):10553-7
   PubMed Web of Science ®Google Scholar
• Yoon SO, Shin S, Lee HJ, Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression. Mol Cancer Ther 2006;5(11):2666-75
   PubMedGoogle Scholar
• Steel RGD, Torrie JH. Principles and procedures of statistics. McGraw-Hill; New York: 1980
   Google Scholar
• Maggiolini M, Statti G, Vivacqua A, Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol 2002;82(4-5):315-22
   PubMed Web of Science ®Google Scholar
• Ma J, Fu NY, Pang DB, Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med 2001;67(8):754-7
   PubMed Web of Science ®Google Scholar
• Baba M, Asano R, Takigami I, Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis. Biol Pharm Bull 2002;25(2):247-50
   PubMedGoogle Scholar
• Hsu YL, Kuo PL, Lin CC. Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells. Life Sci 2005;77(3):279-92
   PubMedGoogle Scholar
• Li L, Liang S, Du F, Li C. Simultaneous quantification of multiple licorice flavonoids in rat plasma. J Am Soc Mass Spectrom 2007;18(4):778-82
   PubMed Web of Science ®Google Scholar
• Cuendet M, Guo J, Luo Y, Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice. Cancer Prev Res (Phila) 2010;3(2):221-32
   PubMedGoogle Scholar
• Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002;12(2):89-96
   PubMedGoogle Scholar
• Sahai E. Illuminating the metastatic process. Nat Rev Cancer 2007;7(10):737-49
   PubMed Web of Science ®Google Scholar
• Mazzocca A, Carloni V. The metastatic process: methodological advances and pharmacological challenges. Curr Med Chem 2009;16(14):1704-17
   PubMedGoogle Scholar
• Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29(6 Suppl 16):15-18
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Miyamoto T, Kimura I, Kimura M. Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro. Biol Pharm Bull 1995;18(10):1382-6
   PubMedGoogle Scholar
• Ye L, Gho WM, Chan FL, Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase. Int J Cancer 2009;124(5):1028-36
   PubMedGoogle Scholar
• Lau GT, Ye L, Leung LK. The licorice flavonoid isoliquiritigenin suppresses phorbol ester-induced cyclooxygenase-2 expression in the non-tumorigenic MCF-10A breast cell line. Planta Med 2010;76(8):780-5
   PubMedGoogle Scholar
• Tamir S, Eizenberg M, Somjen D, Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol 2001;78(3):291-8
   PubMed Web of Science ®Google Scholar
• Nakamura J, Savinov A, Lu Q, Brodie A. Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Endocrinology 1996;137(12):5589-96
   PubMedGoogle Scholar
• Ruohola JK, Valve EM, Karkkainen MJ, Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 1999;149(1-2):29-40
   PubMed Web of Science ®Google Scholar
• Buteau-Lozano H, Ancelin M, Lardeux B, Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 2002;62(17):4977-84
   PubMedGoogle Scholar
• Montagner M, Enzo E, Forcato M, SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature 2012;487(7407):380-4
   PubMed Web of Science ®Google Scholar
• Quaranta M, Daniele A, Coviello M, MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res 2007;27(5B):3593-600
   PubMedGoogle Scholar
• Rangaswami H, Bulbule A, Kundu GC. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. J Biol Chem 2004;279(37):38921-35
   PubMedGoogle Scholar
• Skinner HD, Zheng JZ, Fang J, Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling. J Biol Chem 2004;279(44):45643-51
   PubMed Web of Science ®Google Scholar
• Nakshatri H, Bhat-Nakshatri P, Martin DA, Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997;17(7):3629-39
   PubMed Web of Science ®Google Scholar
• Bond M, Fabunmi RP, Baker AH, Newby AC. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 1998;435(1):29-34
   PubMedGoogle Scholar
• Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 2003;22(4):395-403
   PubMedGoogle Scholar
• Gum R, Wang H, Lengyel E, Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 1997;14(12):1481-93
   PubMedGoogle Scholar
• Simon C, Simon M, Vucelic G, The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp Cell Res 2001;271(2):344-55
   PubMedGoogle Scholar
• Pages G, Berra E, Milanini J, Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem 2000;275(34):26484-91
   PubMedGoogle Scholar
• Jung JI, Chung E, Seon MR, Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells. Biofactors 2006;28(3-4):159-68
   PubMedGoogle Scholar
• Kanazawa M, Satomi Y, Mizutani Y, Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 2003;43(5):580-6
   PubMed Web of Science ®Google Scholar